Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma

Purpose: This study aims to examine the health-related quality of life in patients with hepatocellular carcinoma. Methods: 181 patients attending a tertiary center outpatient clinic were interviewed and completed the short form 36 (SF36) questionnaire. The SF36 was used to assess health-related QoL....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wehling, Cyrill (VerfasserIn) , Hornuß, Daniel (VerfasserIn) , Springfeld, Christoph (VerfasserIn) , Hoffmann, Katrin (VerfasserIn) , Chang, De-Hua (VerfasserIn) , Naumann, Patrick (VerfasserIn) , Mieth, Markus (VerfasserIn) , Longerich, Thomas (VerfasserIn) , Kratochwil, Clemens (VerfasserIn) , Mehrabi, Arianeb (VerfasserIn) , Gauss, Annika (VerfasserIn) , Weiss, Karl Heinz (VerfasserIn) , Pfeiffenberger, Jan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 August 2019
In: Journal of cancer research and clinical oncology
Year: 2019, Jahrgang: 145, Heft: 11, Pages: 2761-2769
ISSN:1432-1335
DOI:10.1007/s00432-019-03005-y
Online-Zugang:Verlag, Volltext: https://doi.org/10.1007/s00432-019-03005-y
Volltext
Verfasserangaben:Cyrill Wehling, Daniel Hornuss, Pasquale Schneider, Christoph Springfeld, Katrin Hoffmann, De-Hua Chang, Patrick Naumann, Markus Mieth, Thomas Longerich, Clemens Kratochwil, Arianeb Mehrabi, Annika Gauss, Karl Heinz Weiss, Jan Pfeiffenberger

MARC

LEADER 00000caa a2200000 c 4500
001 1681878763
003 DE-627
005 20220817024248.0
007 cr uuu---uuuuu
008 191114s2019 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00432-019-03005-y  |2 doi 
035 |a (DE-627)1681878763 
035 |a (DE-599)KXP1681878763 
035 |a (OCoLC)1341250617 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wehling, Cyrill  |d 1989-  |e VerfasserIn  |0 (DE-588)1136431187  |0 (DE-627)892909331  |0 (DE-576)490527817  |4 aut 
245 1 0 |a Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma  |c Cyrill Wehling, Daniel Hornuss, Pasquale Schneider, Christoph Springfeld, Katrin Hoffmann, De-Hua Chang, Patrick Naumann, Markus Mieth, Thomas Longerich, Clemens Kratochwil, Arianeb Mehrabi, Annika Gauss, Karl Heinz Weiss, Jan Pfeiffenberger 
264 1 |c 19 August 2019 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.11.2019 
520 |a Purpose: This study aims to examine the health-related quality of life in patients with hepatocellular carcinoma. Methods: 181 patients attending a tertiary center outpatient clinic were interviewed and completed the short form 36 (SF36) questionnaire. The SF36 was used to assess health-related QoL. Cross-sectional analyses by group (age, gender, clinical scores, systemic, and local interventions) as well sequel questionnaires were conducted. Results: Participants included were 79% (143/181) men [mean age at first SF36: 63.8 (± 12.3; 18.4-85.8) years]. Barcelona Clinic Liver Cancer (BCLC) stadium C was associated with significantly lower SF36 total scores, and elevated initial alpha-fetoprotein (AFP) concentrations were associated with lower SF36 functional and mental health sum scores throughout the course of the third questionnaire. Patients treated with sorafenib had within the sub-dimension scores a significantly lower result for role limitations due to physical health compared to patients without sorafenib treatment. Patients who underwent a transarterial chemoembolization (TACE) had within the sub-dimension scores a significantly higher result for control of pain compared to patients without TACE. Kaplan-Meier analysis revealed significant survival benefits for patients who underwent any intervention at the first SF36 (mean survival in years 4.3 vs. 1.6; P < 0.01) as well as for patients who underwent hepatic resection (mean survival in years 6.3 vs. 2.7; P < 0.0001). Conclusion: Advanced tumor stages marked by BCLC stadium C and elevated initial AFP concentrations were associated with lower SF36 total scores and functional sum scores, respectively. During the course of sorafenib treatment, the sub-dimensional score for role limitations due to physical health decreased significantly, whereas TACE performance was associated with a significant improvement of the control of body pain. 
650 4 |a Hepatocellular carcinoma 
650 4 |a Quality of life 
650 4 |a SF36 
650 4 |a Sorafenib 
650 4 |a TACE 
700 1 |a Hornuß, Daniel  |e VerfasserIn  |0 (DE-588)1047068354  |0 (DE-627)777521237  |0 (DE-576)399927506  |4 aut 
700 1 |a Springfeld, Christoph  |d 1972-  |e VerfasserIn  |0 (DE-588)123388910  |0 (DE-627)706281039  |0 (DE-576)293689385  |4 aut 
700 1 |a Hoffmann, Katrin  |d 1980-  |e VerfasserIn  |0 (DE-588)131774417  |0 (DE-627)513946950  |0 (DE-576)252913078  |4 aut 
700 1 |a Chang, De-Hua  |d 1978-  |e VerfasserIn  |0 (DE-588)132043939  |0 (DE-627)517295210  |0 (DE-576)298911752  |4 aut 
700 1 |a Naumann, Patrick  |d 1981-  |e VerfasserIn  |0 (DE-588)1021553891  |0 (DE-627)715821318  |0 (DE-576)36276266X  |4 aut 
700 1 |a Mieth, Markus  |e VerfasserIn  |0 (DE-588)1071362240  |0 (DE-627)825726573  |0 (DE-576)433041072  |4 aut 
700 1 |a Longerich, Thomas  |d 1974-  |e VerfasserIn  |0 (DE-588)128494514  |0 (DE-627)373916124  |0 (DE-576)297178059  |4 aut 
700 1 |a Kratochwil, Clemens  |d 1978-  |e VerfasserIn  |0 (DE-588)134026276  |0 (DE-627)559871686  |0 (DE-576)300262787  |4 aut 
700 1 |a Mehrabi, Arianeb  |d 1967-  |e VerfasserIn  |0 (DE-588)137664583  |0 (DE-627)594829763  |0 (DE-576)304831263  |4 aut 
700 1 |a Gauss, Annika  |d 1978-  |e VerfasserIn  |0 (DE-588)129331856  |0 (DE-627)393102092  |0 (DE-576)297603523  |4 aut 
700 1 |a Weiss, Karl Heinz  |d 1976-  |e VerfasserIn  |0 (DE-588)130069531  |0 (DE-627)489615465  |0 (DE-576)297980203  |4 aut 
700 1 |a Pfeiffenberger, Jan  |d 1983-  |e VerfasserIn  |0 (DE-588)1019445386  |0 (DE-627)690902514  |0 (DE-576)358082498  |4 aut 
773 0 8 |i Enthalten in  |t Journal of cancer research and clinical oncology  |d Berlin : Springer, 1979  |g 145(2019), 11, Seite 2761-2769  |h Online-Ressource  |w (DE-627)253769515  |w (DE-600)1459285-X  |w (DE-576)072578319  |x 1432-1335  |7 nnas  |a Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma 
773 1 8 |g volume:145  |g year:2019  |g number:11  |g pages:2761-2769  |g extent:9  |a Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma 
856 4 0 |u https://doi.org/10.1007/s00432-019-03005-y  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20191114 
993 |a Article 
994 |a 2019 
998 |g 1019445386  |a Pfeiffenberger, Jan  |m 1019445386:Pfeiffenberger, Jan  |d 910000  |d 910100  |e 910000PP1019445386  |e 910100PP1019445386  |k 0/910000/  |k 1/910000/910100/  |p 14  |y j 
998 |g 130069531  |a Weiss, Karl Heinz  |m 130069531:Weiss, Karl Heinz  |d 910000  |d 910100  |e 910000PW130069531  |e 910100PW130069531  |k 0/910000/  |k 1/910000/910100/  |p 13 
998 |g 129331856  |a Gauss, Annika  |m 129331856:Gauss, Annika  |d 910000  |d 910100  |e 910000PG129331856  |e 910100PG129331856  |k 0/910000/  |k 1/910000/910100/  |p 12 
998 |g 137664583  |a Mehrabi, Arianeb  |m 137664583:Mehrabi, Arianeb  |d 910000  |d 910200  |e 910000PM137664583  |e 910200PM137664583  |k 0/910000/  |k 1/910000/910200/  |p 11 
998 |g 134026276  |a Kratochwil, Clemens  |m 134026276:Kratochwil, Clemens  |d 910000  |d 911400  |e 910000PK134026276  |e 911400PK134026276  |k 0/910000/  |k 1/910000/911400/  |p 10 
998 |g 128494514  |a Longerich, Thomas  |m 128494514:Longerich, Thomas  |d 910000  |d 910200  |e 910000PL128494514  |e 910200PL128494514  |k 0/910000/  |k 1/910000/910200/  |p 9 
998 |g 1071362240  |a Mieth, Markus  |m 1071362240:Mieth, Markus  |d 910000  |d 910200  |e 910000PM1071362240  |e 910200PM1071362240  |k 0/910000/  |k 1/910000/910200/  |p 8 
998 |g 1021553891  |a Naumann, Patrick  |m 1021553891:Naumann, Patrick  |d 910000  |d 911400  |e 910000PN1021553891  |e 911400PN1021553891  |k 0/910000/  |k 1/910000/911400/  |p 7 
998 |g 132043939  |a Chang, De-Hua  |m 132043939:Chang, De-Hua  |d 910000  |d 911400  |d 50000  |e 910000PC132043939  |e 911400PC132043939  |e 50000PC132043939  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 6 
998 |g 131774417  |a Hoffmann, Katrin  |m 131774417:Hoffmann, Katrin  |d 910000  |d 910200  |e 910000PH131774417  |e 910200PH131774417  |k 0/910000/  |k 1/910000/910200/  |p 5 
998 |g 123388910  |a Springfeld, Christoph  |m 123388910:Springfeld, Christoph  |d 910000  |d 910100  |e 910000PS123388910  |e 910100PS123388910  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1047068354  |a Hornuß, Daniel  |m 1047068354:Hornuß, Daniel  |d 910000  |d 910100  |e 910000PH1047068354  |e 910100PH1047068354  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1136431187  |a Wehling, Cyrill  |m 1136431187:Wehling, Cyrill  |d 910000  |d 910100  |e 910000PW1136431187  |e 910100PW1136431187  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1681878763  |e 3540225455 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"9 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1681878763"],"doi":["10.1007/s00432-019-03005-y"]},"relHost":[{"origin":[{"publisher":"Springer","dateIssuedDisp":"1979-","dateIssuedKey":"1979","publisherPlace":"Berlin ; Heidelberg"}],"title":[{"title":"Journal of cancer research and clinical oncology","subtitle":"official organ of the Deutsche Krebsgesellschaft","title_sort":"Journal of cancer research and clinical oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"145(2019), 11, Seite 2761-2769","volume":"145","pages":"2761-2769","year":"2019","issue":"11","extent":"9"},"id":{"eki":["253769515"],"zdb":["1459285-X"],"issn":["1432-1335"]},"note":["Gesehen am 19.03.25","Teils ungezählte Beil.: Supplement"],"disp":"Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinomaJournal of cancer research and clinical oncology","recId":"253769515","language":["eng","ger"],"titleAlt":[{"title":"Cancer research and clinical oncology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["Volume 93, issue 1 (January 1979)-"]}],"note":["Gesehen am 14.11.2019"],"person":[{"family":"Wehling","given":"Cyrill","display":"Wehling, Cyrill","role":"aut"},{"role":"aut","family":"Hornuß","display":"Hornuß, Daniel","given":"Daniel"},{"display":"Springfeld, Christoph","given":"Christoph","family":"Springfeld","role":"aut"},{"family":"Hoffmann","display":"Hoffmann, Katrin","given":"Katrin","role":"aut"},{"display":"Chang, De-Hua","given":"De-Hua","family":"Chang","role":"aut"},{"family":"Naumann","display":"Naumann, Patrick","given":"Patrick","role":"aut"},{"display":"Mieth, Markus","given":"Markus","family":"Mieth","role":"aut"},{"given":"Thomas","display":"Longerich, Thomas","family":"Longerich","role":"aut"},{"role":"aut","family":"Kratochwil","given":"Clemens","display":"Kratochwil, Clemens"},{"role":"aut","family":"Mehrabi","display":"Mehrabi, Arianeb","given":"Arianeb"},{"role":"aut","family":"Gauss","display":"Gauss, Annika","given":"Annika"},{"family":"Weiss","given":"Karl Heinz","display":"Weiss, Karl Heinz","role":"aut"},{"role":"aut","display":"Pfeiffenberger, Jan","given":"Jan","family":"Pfeiffenberger"}],"recId":"1681878763","origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"19 August 2019"}],"name":{"displayForm":["Cyrill Wehling, Daniel Hornuss, Pasquale Schneider, Christoph Springfeld, Katrin Hoffmann, De-Hua Chang, Patrick Naumann, Markus Mieth, Thomas Longerich, Clemens Kratochwil, Arianeb Mehrabi, Annika Gauss, Karl Heinz Weiss, Jan Pfeiffenberger"]},"language":["eng"],"title":[{"title_sort":"Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma","title":"Impact of interventions and tumor stage on health-related quality of life in patients with hepatocellular carcinoma"}]} 
SRT |a WEHLINGCYRIMPACTOFIN1920